New York Life Investment Management LLC Acquires 6,069 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

New York Life Investment Management LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 53,339 shares of the medical equipment provider’s stock after acquiring an additional 6,069 shares during the quarter. New York Life Investment Management LLC’s holdings in Intuitive Surgical were worth $27,841,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of ISRG. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the fourth quarter worth about $82,517,000. Sycomore Asset Management lifted its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.3 %

Shares of ISRG opened at $580.93 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business’s fifty day moving average is $568.10 and its 200 day moving average is $527.65. The stock has a market cap of $206.92 billion, a P/E ratio of 90.63, a P/E/G ratio of 5.85 and a beta of 1.39.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 188 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,240 shares of company stock worth $3,529,040 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ISRG. Bernstein Bank increased their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Truist Financial upped their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.